ConductScience.org, home

Trial · NCT04281784

Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)

NCT04281784, Not applicable, Completed, University of Washington; results first posted 2022-08-01

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1). Trials, record NCT04281784. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04281784

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)
NCT number
NCT04281784
Status
Completed
Phases
Not applicable
Enrollment
2,512 participants, actual
Lead sponsor
University of Washington
Conditions
Dementia, Chronic Disease, Neoplasm Metastasis, Lung Neoplasm, Pulmonary Disease, Chronic Obstructive, Heart Failure,Congestive, Liver Cirrhosis, Kidney Failure, Chronic, Lung Diseases, Interstitial, Peripheral Vascular Disease, Diabetes With End Organ Injury
Interventions
EHR-based Clinician Jumpstart
First posted
2020-02-24
Last updated
2025-04-04
Results first posted
2022-08-01

Source ClinicalTrials.gov

Registered outcomes9

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryProportion of Patients With EHR Documentation of Goals of Care DiscussionsAssessed for the period between randomization and 30 days following randomization
The primary outcome is the proportion of patients who have a goals-of-care (GOC) discussion that has been documented in the EHR in the period between randomization and 30 days following randomization The proportion is the number of patients with GOC documentation over the number of patients in each study arm. Documentation of goals-of-care discussions will be evaluated using our NLP/ML methods.
SecondaryIntensity of Care/ICU Use: ICU AdmissionsAssessed for the period between randomization and 30 days following randomizationSecondary outcomes include measures of intensity of care, including utilization metrics: Number of ICU admissions during the patient's (index) hospital stay will be collected from the EHR.
SecondaryIntensity of Care/ICU Use: ICU Length of Stay (Number of Days Alive and Out of the ICU)Assessed for the period between randomization and 30 days following randomizationSecondary outcomes include measures of intensity of care, including utilization metrics: Number of days alive and out of the ICU within 30 days from randomization will be collected from the EHR.
SecondaryIntensity of Care/Hospital Use: Hospital Length of Stay (Number of Days Alive and Out of the Hospital)Assessed for the period between randomization and 30 days following randomizationSecondary outcomes include measures of intensity of care, including utilization metrics: Number of days alive and out of the hospital within 30 days from randomization will be collected from the EHR.
SecondaryIntensity of Care: Hospital Readmissions 30 DaysAssessed for the period between randomization and 30 days following randomizationSecondary outcomes include measures of intensity of care, including utilization metrics: Proportion of patients readmitted to the hospital following index hospitalization.
SecondaryIntensity of Care: ICU Admissions 30 DaysAssessed for the period between randomization and 30 days following randomizationSecondary outcomes include measures of intensity of care, including utilization metrics: Proportion of patients who received ICU care.
SecondaryTotal Hospitalization Costs, Randomization to 30 Days After RandomizationAssessed for the period between randomization and 30 days laterSecondary outcomes include measures of intensity of care, including costs of inpatient care, collected from UW Medicine Finance Office and adjusted for inflation.
SecondaryAll-cause Mortality at 30 Days After Randomization (Safety Outcome)30 days after randomizationFrom Washington State death certificates
SecondaryTotal Hospitalization Costs, Randomization to Index Hospitalization DischargeIndex hospital stay
Secondary outcomes include measures of intensity of care, including costs of inpatient care, collected from UW Medicine Finance Office and adjusted for inflation. Assessed for the period between randomization and discharge for the index hospital stay.

Outcomes9

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYProportion of Patients With EHR Documentation of Goals of Care DiscussionsAssessed for the period between randomization and 30 days following randomizationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYIntensity of Care/ICU Use: ICU AdmissionsAssessed for the period between randomization and 30 days following randomization
SECONDARYIntensity of Care/ICU Use: ICU Length of Stay (Number of Days Alive and Out of the ICU)Assessed for the period between randomization and 30 days following randomizationdaysMEAN
SECONDARYIntensity of Care/Hospital Use: Hospital Length of Stay (Number of Days Alive and Out of the Hospital)Assessed for the period between randomization and 30 days following randomizationdaysMEAN
SECONDARYIntensity of Care: Hospital Readmissions 30 DaysAssessed for the period between randomization and 30 days following randomizationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYIntensity of Care: ICU Admissions 30 DaysAssessed for the period between randomization and 30 days following randomizationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYTotal Hospitalization Costs, Randomization to 30 Days After RandomizationAssessed for the period between randomization and 30 days later(Data unavailable from Finance Office for two patients.)US dollarsMEAN
SECONDARYAll-cause Mortality at 30 Days After Randomization (Safety Outcome)30 days after randomizationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYTotal Hospitalization Costs, Randomization to Index Hospitalization DischargeIndex hospital stay(Data unavailable from Finance Office for two patients.)US dollarsMEAN

Results by group20

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Proportion of Patients With EHR Documentation of Goals of Care DiscussionsEHR-based Clinician JumpstartGOC documented433Participants
Proportion of Patients With EHR Documentation of Goals of Care DiscussionsUsual CareGOC documented382Participants
Proportion of Patients With EHR Documentation of Goals of Care DiscussionsEHR-based Clinician JumpstartGOC not documented822Participants
Proportion of Patients With EHR Documentation of Goals of Care DiscussionsUsual CareGOC not documented875Participants
Intensity of Care/ICU Use: ICU Length of Stay (Number of Days Alive and Out of the ICU)Usual Care27.90Standard Deviation 6.12days
Intensity of Care/ICU Use: ICU Length of Stay (Number of Days Alive and Out of the ICU)EHR-based Clinician Jumpstart27.83Standard Deviation 6.19days
Intensity of Care/Hospital Use: Hospital Length of Stay (Number of Days Alive and Out of the Hospital)Usual Care21.99Standard Deviation 8.78days
Intensity of Care/Hospital Use: Hospital Length of Stay (Number of Days Alive and Out of the Hospital)EHR-based Clinician Jumpstart21.63Standard Deviation 9.15days
Intensity of Care: Hospital Readmissions 30 DaysEHR-based Clinician Jumpstart265Participants
Intensity of Care: Hospital Readmissions 30 DaysUsual Care251Participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDEHR-based Clinician Jumpstart1,255
Overall StudySTARTEDUsual Care1,257
Overall StudyCOMPLETEDEHR-based Clinician Jumpstart1,255
Overall StudyCOMPLETEDUsual Care1,257
Overall StudyNOT COMPLETEDEHR-based Clinician Jumpstart0
Overall StudyNOT COMPLETEDUsual Care0

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityEHR-based Clinician Jumpstart701,255
Total, all-cause mortalityUsual Care641,257
Total, other adverse eventsEHR-based Clinician Jumpstart01,255
Total, other adverse eventsUsual Care01,257
Total, serious adverse eventsEHR-based Clinician Jumpstart01,255
Total, serious adverse eventsUsual Care01,257

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
35963531BACKGROUNDPubMed
37210665RESULTPubMed
41680079DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons4

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
EHR-based Clinician Jumpstart vs Usual Care: Intensity of Care: ICU Admissions 30 DaysTrial comparisons
EHR-based Clinician Jumpstart vs Usual Care: deaths from any causeTrial comparisons
EHR-based Clinician Jumpstart vs Usual Care: Intensity of Care: Hospital Readmissions 30 DaysTrial comparisons
EHR-based Clinician Jumpstart vs Usual Care: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04281784

GET https://conductscience.org/api/trials/v1/NCT04281784/registered